Replies to post #35545 on Vystar Corp (VYST)

[cjstocksup]

"RxAir - The air purifier trusted by hospitals"
Vystar Corp. (OTC Market: VYST) announced today that new and improved RxAir® UV Light Air Purifiers are now available to combat cold, flu and other airborne germs that are more pervasive during the winter. Vystar acquired RxAir approximately nine months ago and immediately began upgrading the air purifiers to improve performance and longevity. The first upgraded RxAir units are now available for purchase via RxAir.com, Rotmans.com, Rotmans Furniture & Carpet in Worcester, Mass., and RxAir medical distributors.

New units now available feature a higher grade UV light bulb that lasts longer and produces longer UV wave length for more efficient killing/inactivation of bacteria, germs and other pathogens. The new units also offer improved alert codes to more easily identify when action, such as replacing a bulb cartridge, is needed.

Hospitals and healthcare facilities have been using industrial size UV light air purification systems for airborne infection control because they have been proven to inactivate a broad array of airborne viruses and bacteria, including influenza and cold viruses.

“Flu vaccines only protect you from a few flu strains and none of them protect you from the common cold and many other illnesses,” stated Bryan Stone, MD, Internal Medicine and Nephrology, Chief of Medicine for Desert Regional Medical Center. “Using UV light to kill airborne germs has been proven as an effective hospital infection control technology for years. The new RxAir now provides an even more effective way to bring this technology into your home or office to reduce your exposure to these pathogens to help avoid infection.”

Dr. Stone discusses how RxAir works in this video.

“As the new owners of RxAir, Vystar is excited to make RxAir available to the public once again — now in a new and improved format — as we enter the peak cold and flu season period,” stated Steve Rotman, Vystar CEO. “We feel it is critical to have a proven germ killing technology that is relied upon by hospitals to be available for purchase online so homes, schools, restaurants, retail stores and medical offices nationwide can reduce the risk of spreading airborne illnesses.”

RxAir is one of the few UV air purifiers that have been proven in independent EPA- and FDA-certified testing laboratories to destroy on first pass more than 99% of harmful viruses and bacteria. In addition to inactivating airborne viruses that cause influenza and colds, RxAir disarms the airborne pathogens that cause MRSA (staph), strep (whooping cough), tuberculosis (TB), measles, pneumonia and a myriad of other antibiotic-resistant and viral infections.

[doogdilinger]

True game changers like this don't present themselves very often in ones entire OTC penny playing careers right Shaunpro...and as such, many OTC “traders” simply aren't recognizing/comprehending the instantaneous and completely verifiable/justifiable PCAOB DOLLARLAND valuation on deck here!

Rotman's has had 71 years to establish their current level of market penetration...which means their incredible asset base, per annum revenue run rate, and 20% positive net income level, will now provide the most concrete and immediately leverageable foundation imaginable for VYST to immediately begin proceeding through multiple exchange up listings straight onto the Nasdaq in about 6 months’ time!

And VYST's CEO Steve Rotman just spent the past 14 months of his life meticulously working with his VYST directors and investor insiders eliminating/extinguishing approx. $4M of convertible debt off of VYST's books, while simultaneously growing VYST's initial asset base from $200K to just under $3M. And he did all that incredible balance sheet work under the assumption that if everyone involved behind the scenes at VYST agreed to ridding VYST's balance sheet of ALL convertible debt, then he would agree to having VYST acquire 100% of Rotman's, which is exactly what everyone behind the scenes of VYST is doing at this exact juncture...and is exactly why last month’s buyback PR clearly states that VYST mgmt. intends to buy out the last 2 convertible notes the exact same way they just bought out the $105K note announced in last month’s buyback PR...which means Rotmans incredible asset base, revenue run rate and positive net income level is now going to be officially inserted onto a pristine/clean balance sheet with ALL convertible debt removed!

Furthermore, Greg Rotman has been taking the time out of his evenings and weekends to slowly but surely try to introduce himself to every single person who’s called or emailed VYST. And not only is he making the time to get back to everyone he can on a systematic basis over the past few weeks…he’s spending approx. 1 hour on average per intro call going over every single question posed…and he’s providing the utmost clarity possible to everyone he’s called as has been reported back to this forum by multiple posters. He’s also been willing to provide email answers to questions posed…many of which have been posted on this forum as well. Covering every single subject in play these days from the buyback, to how the Rotmans acquisition is being done, to all of the companies and individual products and patents and IP value now underneath the VYST umbrella. And he’s provided all the answers and clarity entirely of his own volition in a personable manner…and pretty much everyone who’s interacted with him has reported back to this forum and flat out stated how impressed they are with his character and integrity exhibited to not shy away from any questions posed whatsoever.

So the bottom line from this precise juncture is simple IMO…as people either believe whole-heartedly that CEO Steve Rotman is the master architect of VYST acquiring his private Rotman’s company or they don’t! It really is that simple…and really does come down to that 1 key intrinsic valuation driving material development now fast approaching on the near-term horizon dictating and determining VYST’s entire future! And when the Rotman’s Super 8k acquisition filing and accompanying fully audited PCAOB financials do get instantly injected onto VYST’s now pristine balance sheet over the very near term horizon now…there’s going to be wave after wave of position building fun initiated here from much higher breeds of investors and firms who immediately begin applying the instant and dramatic increase in valuation metrics the pending official Rotman’s fully audited fins will bring! And when the BIG MONEY accumulation wave begins arriving here, everyone already invested in VYST is in for the journey of their OTC lives through the QB up listing directly ahead, followed by the probable QX up listing in about 3 months’ time, and culminating in the probable Nasdaq up listing application by sometime in late August in my opinion…because it’s simply going to take that long to do all the fully audited financial maneuvering that’s going to be required in order to do a proper and complete Nasdaq up listing application in about 6 months’ time.

None of this now burgeoning VYST growth story is bullshit! VYST itself already files fully audited PCAOB year end 10K financials which are due on March 31st. And Greg Rotman himself has told multiple callers over the past few weeks that the auditors working on the 3 years’ worth of Rotman’s fully audited financials coming are being assisted by the current Rotman’s operations manager and the retired Rotman’s operations manager who the Rotman’s brought back on a contract basis only to assist in the entire Rotman’s integration endeavor into VYST which is a monumental task. So while some impatient hands take the money and run prior to the momentous Rotman’s acquisition upon us…far more patient/savvy hands continue accumulating, knowing full well the Rotman’s acquisition is a colossal game changer here of truly extraordinary proportions…and the PCAOB fully audited financials are as independent and verifiable as it ever gets in the markets…so everyone underestimating the coming explosive impact the Rotman’s numbers will soon bring is definitely in for true shock and awe the likes of which aren’t seen often on any OTC play right cheers!